To determine if neuroinflammatory reactive astrocytes could be a therapeutic target in ALS, we crossed the SOD1G93A mouse line to an IL-1α−/−TNFα−/−C1qa−/− triple knockout mouse line that fails to produce these reactive astrocytes19. The gene discussed is IL1A; the disease is amyotrophic lateral sclerosis.